Y Intercept Hong Kong Ltd Invests $2.73 Million in Bath & Body Works, Inc. $BBWI

Y Intercept Hong Kong Ltd purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 146,443 shares of the company’s stock, valued at approximately $2,734,000.

A number of other institutional investors have also recently added to or reduced their stakes in BBWI. Global Retirement Partners LLC acquired a new position in Bath & Body Works during the fourth quarter worth $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at about $32,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares during the last quarter. Finally, Danske Bank A S acquired a new position in shares of Bath & Body Works during the 3rd quarter worth about $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $20.60 on Wednesday. The company has a 50 day simple moving average of $19.46 and a 200-day simple moving average of $20.41. The company has a market capitalization of $4.15 billion, a P/E ratio of 5.79, a P/E/G ratio of 2.17 and a beta of 1.38. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.96.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a dividend of $0.20 per share. The ex-dividend date was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.9%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Analyst Ratings Changes

Several research firms recently issued reports on BBWI. Wells Fargo & Company lifted their price objective on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a report on Tuesday, June 23rd. The Goldman Sachs Group decreased their target price on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a research report on Thursday, May 28th. Barclays dropped their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. Weiss Ratings downgraded Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, June 2nd. Finally, Morgan Stanley restated an “equal weight” rating and issued a $22.00 price objective on shares of Bath & Body Works in a report on Monday. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $22.29.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.